Publications by authors named "Duncan Mak"

Claim this Profile
D
Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry.
Sammy Ferri-Borgogno, Danielle L Stolley, Basant T Gamal, Christopher D Pacheco, Ivo Veletic, Duncan H Mak

J Vis Exp· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated single cell spatial multi-omics landscape of WHO grades 2-4 diffuse gliomas identifies locoregional metabolomic regulators of glioma growth.
Yanxia Ma, Shamini Ayyadhury, Sanjay Singh, Yashu Vashishath, Cagri Ozdemir, Duncan Mak

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures -ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model.
Bing Z Carter, Po Yee Mak, Wenjing Tao, Lauren B Ostermann, Duncan H Mak

Haematologica· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies.
Wei Shi, Yin Wang, Yuehui Zhao, Justin Jimin Kim, Haoyan Li, Duncan H Mak

Sci Transl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic-Resistant AML and AML Stem Cells.
Bing Z Carter, Po Yee Mak, Wenjing Tao, Qi Zhang, Vivian Ruvolo, Duncan H Mak

Mol Cancer Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibition.
Bing Z Carter, Po Yee Mak, Wenjing Tao, Marc Warmoes, Philip L Lorenzi, Duncan Mak

Haematologica· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML.
Bing Z Carter, Wenjing Tao, Po Yee Mak, Lauren B Ostermann, Duncan Mak

Blood· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy.
Rafet Basar, Nadima Uprety, Emily Ensley, May Daher, Kimberly Klein, Duncan Mak

Cell Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended live-cell barcoding approach for multiplexed mass cytometry.
Muharrem Muftuoglu, Li Li, Shaoheng Liang, Duncan Mak, Angelique J Lin

Sci Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.
May Daher, Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Duncan Mak

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy.
Rafet Basar, Nadima Uprety, Emily Ensley, May Daher, Kimberly Klein, Duncan Mak

bioRxiv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of MDM2 and BCR-ABL1 tyrosine kinase targets chronic myeloid leukemia stem/progenitor cells in a murine model.
Bing Z Carter, Po Yee Mak, Hong Mu, Xiangmeng Wang, Wenjing Tao, Duncan H Mak

Haematologica· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models.
Lina Han, Qi Zhang, Monique Dail, Ce Shi, Antonio Cavazos, Duncan H Mak

Haematologica· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia.
Sankaranarayanan Kannan, Marisa J L Aitken, Shelley M Herbrich, Leonard S Golfman, Mandy G Hall, Duncan H Mak

Mol Cancer Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
Bing Z Carter, Po Yee Mak, Xiangmeng Wang, Wenjing Tao, Vivian Ruvolo, Duncan Mak

Cancer Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in -Mutant Acute Myeloid Leukemia.
Xuejie Jiang, Po Yee Mak, Hong Mu, Wenjing Tao, Duncan H Mak

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy.
Yasmin A Lyons, Sunila Pradeep, Sherry Y Wu, Monika Haemmerle, Jean M Hansen, Duncan H Mak

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal Adhesion Kinase as a Potential Target in AML and MDS.
Bing Z Carter, Po Yee Mak, Xiangmeng Wang, Hui Yang, Guillermo Garcia-Manero, Duncan H Mak

Mol Cancer Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid monoisotopic cisplatin based barcoding for multiplexed mass cytometry.
Ryan L McCarthy, Duncan H Mak, Jared K Burks, Michelle C Barton

Sci Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer.
Hee-Jin Jang, Hyun-Sung Lee, Bryan M Burt, Geon Kook Lee, Kyong-Ah Yoon, Duncan Mak

Gut· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells.
Bing Z Carter, Po Yee Mak, Hong Mu, Hongsheng Zhou, Duncan H Mak

Sci Transl Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells.
Zhihong Zeng, Rui-Yu Wang, Yi Hua Qiu, Duncan H Mak, Kevin Coombes

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network.
Bing Z Carter, Po Yee Mak, Ye Chen, Duncan H Mak, Hong Mu

Oncotarget· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells.
Bing Z Carter, Po Yee Mak, Duncan H Mak, Vivian R Ruvolo, Wendy Schober

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.
Lina Han, Peng Qiu, Zhihong Zeng, Jeffrey L Jorgensen, Duncan H Mak

Cytometry A· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis